首页> 外文学位 >Design and synthesis of novel serotonin receptor ligands.
【24h】

Design and synthesis of novel serotonin receptor ligands.

机译:新型5-羟色胺受体配体的设计和合成。

获取原文
获取原文并翻译 | 示例

摘要

Novel and potent ligands to the serotonin7 (5-HT7) receptor have been synthesized. The synthesized compounds include a set of substituted pyrimidines which show high affinity to the 5-HT7 receptor, synthesized by previously described methods [1,2] in high yield. Comparing the affinities of substituted pyrimidines to previously calculated models [3,4] yielded new hypotheses about the nature of interaction between the pyrimidine ligands and the 5-HT7 binding site. Several new series of compounds were synthesized by various methods to validate these hypotheses, including a conjugate addition to vinylpyrimidines [5]. These compounds include benzofurans, oximes, hydrazones, as well as a group of substituted piperazines. All series of compounds show affinity to the 5-HT7 receptor comparable to previously synthesized 5-HT7 ligands. Several of the synthesized ligands show affinity which exceeds that of currently available ligands.;The synthesized compounds were evaluated quantitatively by calculating a three-dimensional quantitative structure-affinity relationship (3D-QSAR) for the 5-HT7 receptor. Evaluation of the calculated model validated qualitative assumptions about the data set as well as described regions of interaction in greater detail than previously available. These observations give further insight on the nature of ligand-binding site interactions with highly potent ligands such as 4-(3-furyl)-2-(N-methylpiperazino) pyrimidine which will lead to more potent 5-HT7 receptor ligands. Additionally, a model was calculated for affinity to the 5-HT2a receptor. Comparing this model to that calculated for affinity to the 5-HT 7 receptor identified two regions which may be exploited in future sets of ligands to increase selectivity to the 5HT7 receptor.;Index words. Serotonin, 5-HT, Depression, Schizophrenia, Pyrimidine, 1-4 Addition, 3D-QSAR, Molecular modeling, 5-HT7 receptor, 5-HT7 ligands, 5-HT1a, 5-HT2a, Pharmacophore.
机译:已经合成了5-羟色胺7(5-HT7)受体的新型有效配体。合成的化合物包括一组对5-HT7受体表现出高亲和力的取代嘧啶,它们是通过前述方法[1,2]以高收率合成的。将取代的嘧啶的亲和力与先前计算的模型进行比较[3,4],得出了有关嘧啶配体与5-HT7结合位点相互作用性质的新假设。通过各种方法合成了几个新系列的化合物以验证这些假设,包括向乙烯基嘧啶中添加缀合物[5]。这些化合物包括苯并呋喃,肟,和一组取代的哌嗪。与先前合成的5-HT7配体相比,所有系列的化合物均显示出对5-HT7受体的亲和力。几种合成的配体显示出超过目前可用配体的亲和力。通过计算5-HT7受体的三维定量结构亲和关系(3D-QSAR)对合成的化合物进行了定量评估。对计算模型的评估验证了有关数据集以及所描述的交互作用区域的质性假设,其详细程度超过了以往。这些观察结果进一步揭示了与强效配体如4-(3-呋喃基)-2-(N-甲基哌嗪子基)嘧啶的配体结合位点相互作用的性质,这将导致更有效的5-HT7受体配体。另外,计算了对5-HT 2a受体的亲和力的模型。将该模型与针对5-HT 7受体的亲和力模型进行比较,确定了两个区域,可在以后的配体组中利用这两个区域来提高对5HT7受体的选择性。 5-羟色胺,5-HT,抑郁症,精神分裂症,嘧啶,1-4加成,3D-QSAR,分子模型,5-HT7受体,5-HT7配体,5-HT1a,5-HT2a,Pharmacophore。

著录项

  • 作者

    Klenc, Jeffrey D.;

  • 作者单位

    Georgia State University.;

  • 授予单位 Georgia State University.;
  • 学科 Chemistry Organic.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 175 p.
  • 总页数 175
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号